Abstract
We previously reported the emerging role of OX40–OX40L interaction in inflammation and atherosclerosis. However, the mechanism by which OX40–OX40L interaction contributes to pathogenesis is poorly understood. This study investigated the effects of OX40–OX40L interaction on the nuclear factor of activated T cells c1 (NFATc1) in ApoE−/− mice. Atherosclerotic plaque was induced via rapid perivascular carotid collar placement in ApoE−/− mice. The expression levels of OX40, OX40L, and NFATc1 in the lymphocytes were measured via real-time polymerase chain reaction and flow cytometry. The presence of NFATc1 in the atherosclerotic plaque was detected via immunohistochemistry, and the level of IL-4 was measured via enzyme-linked immunosorbent assay. The expression level of NFATc1 significantly increased in atherosclerotic lesion and in the leukocytes from the ApoE−/− mice. After stimulating OX40–OX40L interaction, the mRNA and protein expression levels of NFATc1 in the lymphocytes significantly increased. Meanwhile, anti-OX40LmAb significantly suppressed the expression of NFATc1 in the leukocytes and substantially elevated the level of IL-4. NFATc1 inhibitor markedly suppressed IL-4 production. This study suggests that OX40–OX40L interaction regulates the expression of NFATc1, which may play a critical role in atherosclerotic plaque formation, and may therefore have implications with pathophysiology of atherosclerosis.
Similar content being viewed by others
REFERENCES
Gotsman, I., A.H. Sharpe, and A.H. Lichtman. 2008. T-cell costimulation and coinhibition in atherosclerosis. Circ Res 103: 1220–1231.
Van Wanrooij, E.J., G.H. van Puijvelde, P. de Vos, H. Yagita, T.J. van Berkel, and J. Kuiper. 2007. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27: 204–210.
Hogan, P.G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium calcineurin, and NFAT. Genes Dev 17: 2205–2232.
Macian, F. 2005. NFAT proteins: Key regulators of T-cell development and function. Nat Rev Immunol 5: 472–484.
Macian, F., C. Garcia-Rodriguez, and A. Rao. 2000. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19: 4783–4795.
de la Pompa, J.L., L.A. Timmerman, H. Takimoto, H. Yoshida, A.J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B.L. Langille, G.R. Crabtree, and T.W. Mak. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182–186.
Ranger, A.M., M.J. Grusby, M.R. Hodge, E.M. Gravallese, F.C. de la Brousse, T. Hoey, C. Mickanin, H.S. Baldwin, and L.H. Glimcher. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186–190.
Sieber, M., and R. Baumgrass. 2009. Novel inhibitors of the calcineurin/NFATc hub—Alternatives to CsA and FK506. Cell Commun Signal 7: 25.
Karpurapu, M., D. Wang, N.K. Singh, Q. Li, and G.N. Rao. 2008. NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis. J Biol Chem 283: 26577–26590.
Croft, M. 2003. Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? Nat Rev Immuno 3: 609–620.
Watts, T.H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23–68.
Sugamura, K., N. Ishii, and A.D. Weinberg. 2004. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 4: 420–431.
Monticelli, S., and A. Rao. 2002. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur J Immunol 32: 2971–2978.
Liu, D.M., J.C. Yan, C.P. Wang, G.H. Chen, S. Ding, P.J. Liu, and R.Z. Du. 2008. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome. Clin Chim Acta 397: 22–26.
von der Thusen, J.H., T.J. van Berkel, and E.A. Biessen. 2001. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103: 1164–1170.
Takeda, I., S. Ine, N. Killeen, L.C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii. 2004. Distinct roles for the OX40–OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 172: 3580–3589.
Peng, D.Q., S. Huang, S.G. Yuan, and S.P. Zhao. 2010. Increased soluble OX40L is associated with carotid intima-media thickness. Clin Lab 56: 449–457.
Nakano, M., Y. Fukumoto, K. Satoh, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa. 2010. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization. Cardiovasc Res 88: 539–546.
Yan, J., C. Wang, R. Du, P. Liu, and G. Chen. 2009. OX40–OX40L ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells. Chem Biol Interact 180: 460–464.
Kim, M.S., and Y.M. Usachev. 2009. Mitochondrial Ca2+ cycling facilitates activation of the transcription factor NFAT in sensory neurons. J Neurosci 29: 12101–12114.
ACKNOWLEDGMENTS
This project was supported by the Natural Science Foundation of Jiangsu Province, China (BK2011486, LJ201116) and the National Natural Science Foundation of China (81170279, 81370409) and Key Laboratory of Cardiovascular Disease of Zhenjiang (SS2012002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yan, Jc., Xu, Lj., Wang, Cp. et al. Effects of OX40–OX40L Interaction on the Nuclear Factor of Activated T Cells c1 in ApoE-Deficient Mice. Inflammation 37, 205–213 (2014). https://doi.org/10.1007/s10753-013-9731-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-013-9731-y